Clinical Trial Update: Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers

View source ↗

Summary

A completed clinical trial from Memorial Sloan Kettering studied how common paraneoplastic autoantibodies are across several cancers and whether they have clini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hodgkin Lymphoma
• Lung Cancer
• Neuroblastoma
• Ovarian Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer, Ovarian Cancer | Status: COMPLETED